In a groundbreaking study, TIM-3 Alzheimer's treatment has emerged as a promising avenue for addressing the cognitive decline associated with Alzheimer's disease.Researchers have highlighted the TIM-3 molecule's potential in regulating the hyperactive immune response in the brain, which plays a critical role in plaque accumulation.